Opi Pharma Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
as on 12-01-2025
- Paid Up Capital ₹ 6.05 Cr
as on 12-01-2025
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 46.00 Cr
as on 12-01-2025
- Satisfied Charges ₹ 29.50 Cr
as on 12-01-2025
- Revenue %
(FY 2023)
- Ebitda
- Net Worth
- Total Assets 48.16%
(FY 2023)
About Opi Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 6.05 Cr.
The company currently has active open charges totaling ₹46.00 Cr. The company has closed loans amounting to ₹29.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Goyal, Ranjna Goyal, Abhishek Singla, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24230HR2021PTC094384
- Company No.
094384
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Apr 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Opi Pharma?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Goyal  | Director | 12-Apr-2021 | Current |
| Ranjna Goyal | Director | 12-Apr-2021 | Current |
| Abhishek Singla | Director | 30-Dec-2023 | Current |
| Rayma Singla | Director | 30-Dec-2023 | Current |
| Rakshit Goyal | Additional Director | 06-Apr-2023 | Current |
| Pankaj Jain | Additional Director | 13-Apr-2023 | Current |
Financial Performance of Opi Pharma.
Opi Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Opi Pharma?
Unlock access to Opi Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Opi Dermaceuticals Private LimitedActive 3 years 9 monthsRakesh Goyal, Ranjna Goyal and 3 more are mutual person
- Rrg Biotech Private LimitedActive 3 years 9 months
Rakesh Goyal, Ranjna Goyal and 3 more are mutual person
- Aqua Parenteral Private LimitedActive 3 years 9 months
Rakesh Goyal, Ranjna Goyal and 1 more are mutual person
- Opi Pallets Private LimitedActive 3 years 9 months
Rakesh Goyal, Ranjna Goyal and 1 more are mutual person
- Opi Group Global Private LimitedActive 9 months 27 days
Rakesh Goyal, Ranjna Goyal and 1 more are mutual person
- R R Biotec India Private LimitedActive 10 years 25 days
Rakesh Goyal, Ranjna Goyal and 1 more are mutual person
Charges (Loans)
₹46.00 Cr
₹29.50 Cr
Charges Breakdown by Lending Institutions
- Others : 46.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Sep 2023 | Others | ₹43.50 Cr | Open |
| 12 Sep 2023 | Others | ₹2.50 Cr | Open |
| 25 Apr 2023 | Others | ₹2.50 Cr | Satisfied |
| 25 Apr 2023 | Others | ₹27.00 Cr | Satisfied |
How Many Employees Work at Opi Pharma?
Opi Pharma has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Opi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Opi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.